222 related articles for article (PubMed ID: 31481263)
1. Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation.
Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Uemoto S
Clin Nutr; 2020 Jun; 39(6):1885-1892. PubMed ID: 31481263
[TBL] [Abstract][Full Text] [Related]
2. Impact of Skeletal Muscle Mass Index, Intramuscular Adipose Tissue Content, and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation.
Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Shirai H; Yagi S; Kamo N; Okajima H; Uemoto S
Transplantation; 2017 Mar; 101(3):565-574. PubMed ID: 27926595
[TBL] [Abstract][Full Text] [Related]
3. Proposal of Muscle-MELD Score, Including Muscularity, for Prediction of Mortality After Living Donor Liver Transplantation.
Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Shirai H; Yagi S; Hammad A; Okajima H; Uemoto S
Transplantation; 2016 Nov; 100(11):2416-2423. PubMed ID: 27495765
[TBL] [Abstract][Full Text] [Related]
4. Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis.
Ebadi M; Tandon P; Moctezuma-Velazquez C; Ghosh S; Baracos VE; Mazurak VC; Montano-Loza AJ
J Hepatol; 2018 Sep; 69(3):608-616. PubMed ID: 29709682
[TBL] [Abstract][Full Text] [Related]
5. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
da Silva Machado AG; de Medeiros Fleck A; Marroni C; Zanotelli ML; Cantisani G; de Mello Brandão AB
Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
[TBL] [Abstract][Full Text] [Related]
6. The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality.
Starlinger P; Ahn JC; Mullan A; Gyoeri GP; Pereyra D; Alva-Ruiz R; Hackl H; Reiberger T; Trauner M; Santol J; Simbrunner B; Mandorfer M; Berlakovich G; Kamath PS; Heimbach J
Hepatology; 2021 Sep; 74(3):1533-1545. PubMed ID: 33786862
[TBL] [Abstract][Full Text] [Related]
7. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.
Gotthardt D; Weiss KH; Baumgärtner M; Zahn A; Stremmel W; Schmidt J; Bruckner T; Sauer P
BMC Gastroenterol; 2009 Sep; 9():72. PubMed ID: 19778459
[TBL] [Abstract][Full Text] [Related]
8. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
[TBL] [Abstract][Full Text] [Related]
9. Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases.
Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
World J Surg; 2018 Apr; 42(4):1180-1191. PubMed ID: 28936708
[TBL] [Abstract][Full Text] [Related]
10. Visceral adiposity is an independent risk factor for high intra-operative blood loss during living-donor liver transplantation; could preoperative rehabilitation and nutritional therapy mitigate that risk?
Macshut M; Kaido T; Yao S; Miyachi Y; Sharshar M; Iwamura S; Hirata M; Shirai H; Kamo N; Yagi S; Uemoto S
Clin Nutr; 2021 Mar; 40(3):956-965. PubMed ID: 32665100
[TBL] [Abstract][Full Text] [Related]
11. Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation.
Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Okajima H; Uemoto S
J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):246-254. PubMed ID: 29453829
[TBL] [Abstract][Full Text] [Related]
12. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
Abdallah MA; Kuo YF; Asrani S; Wong RJ; Ahmed A; Kwo P; Terrault N; Kamath PS; Jalan R; Singal AK
J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
[TBL] [Abstract][Full Text] [Related]
13. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
[TBL] [Abstract][Full Text] [Related]
14. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
[TBL] [Abstract][Full Text] [Related]
15. Multiple Regional Listing Increases Liver Transplant Rates for Those With Model for End-stage Liver Disease Score <15.
Brown S; Savva Y; Barth R; LaMattina J; Thuluvath PJ
Transplantation; 2020 Apr; 104(4):762-769. PubMed ID: 31568393
[TBL] [Abstract][Full Text] [Related]
16. A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study.
Wang CW; Feng S; Covinsky KE; Hayssen H; Zhou LQ; Yeh BM; Lai JC
Transplantation; 2016 Aug; 100(8):1692-8. PubMed ID: 27314169
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Waitlist Mortality in Portopulmonary Hypertension.
DuBrock HM; Goldberg DS; Sussman NL; Bartolome SD; Kadry Z; Salgia RJ; Mulligan DC; Kremers WK; Kawut SM; Krowka MJ; Channick RN
Transplantation; 2017 Jul; 101(7):1609-1615. PubMed ID: 28207639
[TBL] [Abstract][Full Text] [Related]
18. Impact of Skeletal Muscle Mass, Muscle Quality, and Visceral Adiposity on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma.
Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Fujimoto Y; Iida T; Yagi S; Taura K; Hatano E; Okajima H; Uemoto S
Ann Surg Oncol; 2017 Apr; 24(4):1037-1045. PubMed ID: 27837297
[TBL] [Abstract][Full Text] [Related]
19. MELD-XI Score and Coronary Artery Disease Prevalence and Extent Among In-Hospital Patients With End-Stage Liver Failure Awaiting Transplant.
Keskin S; Çiftci O; Moray G; Müderrisoğlu H; Haberal M
Exp Clin Transplant; 2020 Jan; 18(Suppl 1):88-92. PubMed ID: 32008505
[TBL] [Abstract][Full Text] [Related]
20. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.
Ahn J; Bhuket T; Mosadeghi S; Frenette C; Liu B; Wong RJ
Hepatol Int; 2016 Sep; 10(5):838-46. PubMed ID: 27221700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
